Stocks & Investing
Tue, September 17, 2024
[ Tue, Sep 17th 2024
] - WOPRAI
Wed, September 11, 2024
[ Wed, Sep 11th 2024
] - WOPRAI
Mon, August 19, 2024
[ Mon, Aug 19th 2024
] - WOPRAI
Wed, August 7, 2024
[ Wed, Aug 07th 2024
] - WOPRAI
Tue, June 25, 2024
[ Tue, Jun 25th 2024
] - WOPRAI
Fri, May 10, 2024
[ Fri, May 10th 2024
] - WOPRAI
Fri, April 12, 2024
[ Fri, Apr 12th 2024
] - WOPRAI
Wed, March 13, 2024
[ Wed, Mar 13th 2024
] - WOPRAI
Wed, January 3, 2024
[ Wed, Jan 03rd 2024
] - WOPRAI
Wed, December 27, 2023
[ Wed, Dec 27th 2023
] - WOPRAI
Wed, October 11, 2023
[ Wed, Oct 11th 2023
] - WOPRAI
Fri, September 8, 2023
[ Fri, Sep 08th 2023
] - WOPRAI
Tue, August 15, 2023
[ Tue, Aug 15th 2023
] - WOPRAI
Fri, July 28, 2023
[ Fri, Jul 28th 2023
] - WOPRAI
Fri, July 21, 2023
[ Fri, Jul 21st 2023
] - WOPRAI
Thu, July 20, 2023
[ Thu, Jul 20th 2023
] - WOPRAI
Thu, May 4, 2023
[ Thu, May 04th 2023
] - WOPRAI
Fri, April 21, 2023
[ Fri, Apr 21st 2023
] - WOPRAI
[ Fri, Apr 21st 2023
] - WOPRAI
Thu, January 5, 2023
[ Thu, Jan 05th 2023
] - WOPRAI
Wed, December 14, 2022
[ Wed, Dec 14th 2022
] - WOPRAI
Mon, December 5, 2022
[ Mon, Dec 05th 2022
] - WOPRAI
Tue, June 21, 2022
[ Tue, Jun 21st 2022
] - WOPRAI
Fri, April 22, 2022
[ Fri, Apr 22nd 2022
] - WOPRAI
Mon, March 28, 2022
[ Mon, Mar 28th 2022
] - WOPRAI
Thu, March 17, 2022
[ Thu, Mar 17th 2022
] - WOPRAI
Thu, February 3, 2022
[ Thu, Feb 03rd 2022
] - WOPRAI
Fri, January 21, 2022
[ Fri, Jan 21st 2022
] - WOPRAI
Wed, January 5, 2022
[ Wed, Jan 05th 2022
] - WOPRAI
Thu, December 23, 2021
[ Thu, Dec 23rd 2021
] - WOPRAI
Geoff Meacham Maintained (BMRN) at Strong Buy with Decreased Target to $115 on, Sep 17th, 2024
Geoff Meacham of B of A Securities, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy with Decreased Target from $130 to $115 on, Sep 17th, 2024.
Geoff has made no other calls on BMRN in the last 4 months.
There are 8 other peers that have a rating on BMRN. Out of the 8 peers that are also analyzing BMRN, 2 agree with Geoff's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Whitney Ijem of "Canaccord Genuity" Maintained at Hold and Held Target at $93 on, Friday, September 13th, 2024
- Joel Beatty of "Baird" Downgraded from Buy to Hold and Decreased Target to $72 on, Friday, May 17th, 2024
These are the ratings of the 6 analyists that currently disagree with Geoff
- Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $110 on, Monday, September 9th, 2024
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $122 on, Thursday, September 5th, 2024
- Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $120 on, Thursday, September 5th, 2024
- Cory Kasimov of "Evercore ISI Group" Maintained at Buy with Increased Target to $115 on, Tuesday, August 6th, 2024
- Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $110 on, Tuesday, August 6th, 2024
- Phil Nadeau of "TD Cowen" Maintained at Strong Buy with Decreased Target to $120 on, Tuesday, August 6th, 2024
